Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

CD22-CART

Home DrugsCD22-CART

CD22-CART

Unknown Manufacturer

Generate AI report

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Patents

One entry per invention. Patent families filed in the US, EP, WO and CN offices.

Preparation method of mixed CART cells of target CD19 and target CD22
Applicant: SHANGHAI HRAIN BIOTECHNOLOGY CO LTDPriority: 2018
CN
Preparation method and applications of CART cell prepared by equally mixing two target CART cells
Applicant: SHANGHAI HRAIN BIOTECHNOLOGY CO LTDPriority: 2017
CN
Chimeric antigen receptor targeting CD22 and application for chimeric antigen receptor
Applicant: BEIJING SHUANGYING KECHUANG BIO TECH CO LTDPriority: 2020
CN
Combined chimerism antigen receptor, expression vector, lentivirus and T-cell
Applicant: WUHAN BIO RAID BIOTECHNOLOGY CO LTDPriority: 2018
CN
Polyspecific Binding Molecules and their use in Cell Therapy
Applicant: INNOVATIVE CELLULAR THERAPEUTICS HOLDINGS LTDPriority: 2021
US